Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer accounting for 80% of all renal cancers as well as the majority of renal cancer-associated deaths. During the last decade, the treatment paradigm for ccRCC has radically changed. In particular, the recent development of immune c...
Main Authors: | Laura K. Esser, Vittorio Branchi, Sonia Leonardelli, Natalie Pelusi, Adrian G. Simon, Niklas Klümper, Jörg Ellinger, Stefan Hauser, Maria A. Gonzalez-Carmona, Manuel Ritter, Glen Kristiansen, Hubert Schorle, Michael Hölzel, Marieta I. Toma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01775/full |
Similar Items
-
A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma
by: Xiaohui Zhan, et al.
Published: (2020-12-01) -
Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer
by: Joanna Bialek, et al.
Published: (2021-07-01) -
Role of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
by: Sara Clerici, et al.
Published: (2020-11-01) -
VHL and Hypoxia Signaling: Beyond HIF in Cancer
by: Jing Zhang, et al.
Published: (2018-03-01) -
Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
by: Jing Ma, et al.
Published: (2020-03-01)